This result not only extends previous findings of an association between serum CRP levels ≥0.5–0.6 mg/dl and progression of SSc-ILD [24, 25], but is also in line with recent studies showing that the slight elevation of serum CRP levels predict poor prognosis in various chronic diseases [26–28]. Here, CRP is linked to systemic sclerosis.